Literature DB >> 19349135

MRI appearance of mesenchymal tumors of the uterus.

Daniel Cornfeld1, Gary Israel, Maritza Martel, Jeffery Weinreb, Peter Schwartz, Shirley McCarthy.   

Abstract

PURPOSE: Uterine leiomyomas are the most common uterine neoplasms. Statistically, a uterine mass with unusual imaging features is more likely to represent a leiomyoma than other uncommon uterine mesenchymal neoplasms such as leiomyosarcoma or endometrial stromal tumors. Several prior studies have attempted to identify objective imaging characteristics that differentiate these entities. The purpose of this study was to test these criteria on our patient population. METHODS AND MATERIALS: This retrospective study was approved by the institutional Human Investigations Committee and was performed in compliance with HIPAA regulations. Four patients with uterine leiomyosarcoma, two with stromal tumors of uncertain malignant potential (STUMP), one with endometrial stromal sarcoma, and two with mixed endometrial stromal and smooth muscle tumors were included in the study. Seventeen additional control cases of leiomyomas were selected as controls. Cases were blindly evaluated by two experienced readers. Objective criteria included T1 and T2 signal characteristics, enhancement pattern, the presence of cystic changes, and ill defined margins. Subjective criteria included individual reader gestalt. All cases had pathologic correlation.
RESULTS: None of the objective criteria were associated with the presence or absence of uterine mesenchymal neoplasm. Ill defined margins came closest to having statistical significance (p=0.06). Reader gestalt was statistically associated with the presence of mesenchymal neoplasm for one of our readers (p=0.02) but not for the other (p=0.07).
CONCLUSION: We found poor accuracy for objective imaging criteria in distinguishing leiomyomas with atypical imaging features from more clinically significant uterine mesenchymal neoplasms. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19349135     DOI: 10.1016/j.ejrad.2009.03.005

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  19 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Authors:  Yulia Lakhman; Harini Veeraraghavan; Joshua Chaim; Diana Feier; Debra A Goldman; Chaya S Moskowitz; Stephanie Nougaret; Ramon E Sosa; Hebert Alberto Vargas; Robert A Soslow; Nadeem R Abu-Rustum; Hedvig Hricak; Evis Sala
Journal:  Eur Radiol       Date:  2016-12-05       Impact factor: 5.315

Review 3.  Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Authors:  Martee L Hensley; Brigitte A Barrette; Klaus Baumann; David Gaffney; Anne L Hamilton; Jae-Weon Kim; Johanna U Maenpaa; Patricia Pautier; Nadeem Ahmad Siddiqui; Anneke M Westermann; Isabelle Ray-Coquard
Journal:  Int J Gynecol Cancer       Date:  2014-11       Impact factor: 3.437

Review 4.  Soft Tissue and Uterine Leiomyosarcoma.

Authors:  Suzanne George; César Serrano; Martee L Hensley; Isabelle Ray-Coquard
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

5.  Hydropic leiomyoma of the uterus presenting as a giant abdominal mass.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Oliveira; Paula Magro
Journal:  BMJ Case Rep       Date:  2015-09-08

6.  Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma.

Authors:  Jasmine H Francis; Ruth A Kleinerman; Johanna M Seddon; David H Abramson
Journal:  Gynecol Oncol       Date:  2011-10-23       Impact factor: 5.482

Review 7.  Medical Device Safety and Surgical Dissemination of Unrecognized Uterine Malignancy: Morcellation in Minimally Invasive Gynecologic Surgery.

Authors:  Tracilyn Hall; Susanna I Lee; David M Boruta; Annekathryn Goodman
Journal:  Oncologist       Date:  2015-09-17

8.  Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.

Authors:  Jyothi P Jagannathan; Aida Steiner; Camden Bay; Eric Eisenhauer; Michael G Muto; Suzanne George; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2021-06-01

9.  Fibromatous uterus in a 16-year-old girl: a case report.

Authors:  Athina C Tsili; Ekaterini D Lentoudi; Maria I Argyropoulou; Nikolaos Dalkalitsis; Anna Batistatou; Evangelos Paraskevaidis; Konstantine Tsampoulas
Journal:  Case Rep Med       Date:  2010-11-28

Review 10.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.